Delivery Order SPE2DB22D3501-SPE2DB25FWV52
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $8,630.28 to AmerisourceBergen Drug Corp for OFEV 100 mg capsules (60-count units) on August 15, 2025, with completion targeted for September 8, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. OFEV (nintedanib) is a prescription medication used to treat idiopathic pulmonary fibrosis...
- The Defense Logistics Agency awarded a delivery order valued at $25,771.74 to AmerisourceBergen Drug Corp for OFEV 150 mg capsules (60-count units) on August 18, 2025, with an ultimate completion date of September 9, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. OFEV (nintedanib) is a specialty pharmaceutical used in the treatment of pulmonary fibrosis...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of OFEV (nintedanib) 100 mg capsules in quantities of 60 units, with a contract ceiling value of $8,630.28. This is a firm fixed-price delivery order with no set-aside designation, issued under open competition. The ultimate completion date is September 9, 2025, and the place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. OFEV...
- The Defense Logistics Agency awarded a delivery order valued at $8,590.58 to AmerisourceBergen Drug Corp for OFEV (nintedanib) 150 mg capsules (60-count units) on July 18, 2025, with an ultimate completion date of August 8, 2025. This firm fixed-price delivery order represents a non-set-aside award, indicating it was competitively procured. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child contract action, this delivery order is...
- The Defense Logistics Agency awarded a $8,630.28 firm fixed-price delivery order to AmerisourceBergen Drug Corp for OFEV (nintedanib) 100 mg capsules (60-count units) on July 30, 2025, with an ultimate completion date of August 20, 2025. This non-set-aside contract is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement,...
- The Defense Logistics Agency awarded a delivery order valued at $8,630.28 to AmerisourceBergen Drug Corp for OFEV (nintedanib) 100 mg capsules in a 60-count configuration. This competitive delivery order, issued on July 18, 2025, with an ultimate completion date of August 8, 2025, represents a firm fixed-price pharmaceutical procurement to support federal medical supply needs. The award was made without a set-aside designation, indicating it was competitively awarded among qualified vendors....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for OFEV (pirfenidone) 100 mg capsules in a 60-count package, valued at $8,630.28. This competitively awarded, firm fixed price delivery order is scheduled for completion by September 9, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. No set-aside designation was applied to this procurement. This delivery order is issued under AmerisourceBergen Drug Corp's larger...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $25,771.74 to AmerisourceBergen Drug Corp for the supply of OFEV (nintedanib) 150 mg capsules in quantities of 60 units. This is a firm fixed price delivery order with an ultimate completion date of August 14, 2025, and represents a non-set-aside competitive award. The work will be performed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Ofev 100 mg capsules (60-count units) with a ceiling value of $17,260.58. This firm fixed-price delivery order, which is expected to be completed by September 2, 2025, represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. Ofev (nintedanib) is a medication...
- The Defense Logistics Agency awarded a $7,643.51 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 100 mg capsules of OFEV to treat idiopathic pulmonary fibrosis. Amerisourcebergen will deliver 60 capsules to a facility in Conshohocken, Pennsylvania under a contract starting on September 21, 2023 and ending on October 13, 2023. As a major provider of pharmaceuticals and medical supplies to the Department of Defense, this order for OFEV capsules supports the DLA's...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB25FWV52Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $8.6K to AmerisourceBergen Drug Corp for OFEV 100 mg capsules (60 count) on August 12, 2025, with completion targeted for September 3, 2025. This firm fixed-price delivery order was awarded without a set-aside designation through open competition and will be performed at the company's corporate headquarters in Conshohocken, Pennsylvania. OFEV (nintedanib) is a tyrosine kinase inhibitor primarily used to treat idiopathic pulmonary fibrosis, supporting the Defense Health Agency's pharmaceutical supply requirements for military healthcare systems. This delivery order represents a tactical procurement under AmerisourceBergen Drug Corp's substantial Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.9M through December 2026. The broader IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply diverse medications, vaccines, and medical commodities to military healthcare programs worldwide. AmerisourceBergen's position as a major pharmaceutical distributor with extensive federal contracting experience demonstrates its capability to fulfill specialized medical procurement needs for the Defense Department's healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.6k | 8/12/25 |